Lilly Plans ‘Big, Bold’ Launch For Zepbound
Lilly expects the obesity drug will be fully accessible in a therapeutic area that has experienced short supply. The list price will be 20% lower than the price of Wegovy.
Lilly expects the obesity drug will be fully accessible in a therapeutic area that has experienced short supply. The list price will be 20% lower than the price of Wegovy.